compound tirzepatide cost TrimRX led and built for women Compounded Tirzepatide (GLP-1/GIP)

Healthy glucose balance is shaped by carbohydrate intake, physical movement, sleep quality, stress, and multiple lifestyle variables that no patch addresses directly

8% fewer CV events 7% fewer hospitalisations 7% fewer bed days than a glucose management approach GBP ~1.68 billion in UK cost savings by 2040

The differences in discontinuation rates between MariTide and other GLP-1 receptor agonists are notable, with approximately 65% of individuals without Type 2 diabetes discontinuing MariTide treatment within a year compared to around 47% for those with diabetes

MCD are highly heterogenous in genotype and phenotype and the spatial and temporal context the malformation is occurring in can inform the size and location of the malformation

doi: 10.2337/diabetes.54.2.482 37 LiYHansotiaTYustaBRisFHalbanPADruckerDJ